RARE DISEASERESEARCH ATLAS

ORPHA:811

Shwachman-Diamond syndrome

medium confidenceDisorder

Also known as: Pancreatic insufficiency and bone marrow dysfunction · SDS · Shwachman syndrome · Shwachman-Bodian-Diamond syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

2,347

94.2th percentile

Trials

10

Interventional, condition-specific

Researchers

1,215

Distinct authors in sample

Gene link

EIF6, SBDS, SRPRA

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

Shwachman-Diamond syndrome (SDS) is a rare multisystemic syndrome characterized by chronic and usually mild neutropenia, pancreatic exocrine insufficiency associated with steatorrhea and growth failure, skeletal with short stature, and an increased risk of bone marrow aplasia or leukemic transformation.

How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (4)

Schwachman-Diamond syndrome · Schwachmann-Diamond syndrome · Shwachman Diamond Syndrome · pancreatic insufficiency and bone marrow dysfunction

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedPresent

    Definitive — EIF6, SBDS, SRPRA

  2. LiteraturePresent

    2,347 matched papers (1,327 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    10 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (EIF6, SBDS, SRPRA).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

2,347

2,347 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

2,347 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

1,327 in the last 10 years · medium confidence · 94.2th percentile (publications denominator)

Phrase hits: 2,347 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,215

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Cipolli M17 papers · 2026

    Cystic Fibrosis Center of Verona, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.

    Papers in Europe PMC
  2. 02
    Bezzerri V14 papers · 2026

    Cystic Fibrosis Center of Verona, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.

    Papers in Europe PMC
  3. 03
    Shimamura A10 papers · 2026

    Bone Marrow Failure and Myelodysplastic Syndrome Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.

    Papers in Europe PMC
  4. 04
    Cesaro S9 papers · 2026

    Unit of Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.

    Papers in Europe PMC
  5. 05
    Myers KC8 papers · 2026

    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. Electronic address: Kasiani.myers@cchmc.org.

    Papers in Europe PMC
  6. 06
    Valli R8 papers · 2026

    Department of Medicine and Surgery (DMC), Universita' degli Studi dell'Insubria, Via J.H. Dunant, 5, 21100 Varese, Italy.

    Papers in Europe PMC
  7. 07
    Corey SJ7 papers · 2026

    Departments of Pediatrics and Cancer Biology, Cleveland Clinic, Cleveland, OH. coreys2@ccf.org.

    Papers in Europe PMC
  8. 08
    Pegoraro A7 papers · 2026

    Cystic Fibrosis Center of Verona, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.

    Papers in Europe PMC
  9. 09
    Donadieu J6 papers · 2026

    Department of Paediatric Haematology and Oncology, Registre National des Neutropénies Chroniques, AP-HP Trousseau Hospital, Paris, France.

    Papers in Europe PMC
  10. 10
    Loveless S6 papers · 2026

    Boston Children’s Hospital

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

10

interventional trials for this specific condition

10 interventional trials matched this specific condition name; none in our sample are currently recruiting.

Data as of 27 July 2026

10 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 91.7th percentile).

medium confidence · 91.7th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

10 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Observational and natural-history studies

6 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Shwachman-Diamond syndrome" OR "Pancreatic insufficiency and bone marrow dysfunction" OR "Shwachman syndrome" OR "Shwachman-Bodian-Diamond syndrome" OR "Schwachman-Diamond syndrome" OR "Schwachmann-Diamond syndrome" OR "Shwachman Diamond Syndrome"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Shwachman-Diamond syndrome" OR "Pancreatic insufficiency and bone marrow dysfunction" OR "Shwachman syndrome" OR "Shwachman-Bodian-Diamond syndrome" OR "Schwachman-Diamond syndrome" OR "Schwachmann-Diamond syndrome" OR "Shwachman Diamond Syndrome" OR "EIF6" OR "SBDS" OR "SRPRA"

Recall-expansion terms: EIF6, SBDS, SRPRA

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 10 interventional · 6 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: SDS

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-26T15:30:11.009Z